Braun, J., and J. Sieper. 2007. Ankylosing spondylitis. Lancet 369 (9570): 1379–1390.

Article  PubMed  Google Scholar 

Maksymowych, W.P. 2010. Disease modification in ankylosing spondylitis. Nature Reviews Rheumatology 6 (2): 75–81.

Article  PubMed  Google Scholar 

Navarro-Compán, V., A. Sepriano, B. El-Zorkany, and D. van der Heijde. 2021. Axial spondyloarthritis. Annals of the Rheumatic Diseases 80 (12): 1511–1521.

Article  PubMed  Google Scholar 

Liu, L., Y. Yuan, S. Zhang, J. Xu, and J. Zou. 2021. Osteoimmunological insights into the pathogenesis of ankylosing spondylitis. Journal of Cellular Physiology 236 (9): 6090–6100.

Article  CAS  PubMed  Google Scholar 

Miossec, P., and J.K. Kolls. 2012. Targeting IL-17 and TH17 cells in chronic inflammation. Nature Reviews Drug Discovery 11 (10): 763–776.

Article  CAS  PubMed  Google Scholar 

Yang, J., M.S. Sundrud, J. Skepner, and T. Yamagata. 2014. Targeting Th17 cells in autoimmune diseases. Trends in Pharmacological Sciences 35 (10): 493–500.

Article  CAS  PubMed  Google Scholar 

Gracey, E., Y. Yao, B. Green, Z. Qaiyum, Y. Baglaenko, A. Lin, A. Anton, R. Ayearst, P. Yip, and R.D. Inman. 2016. Sexual dimorphism in the Th17 signature of ankylosing spondylitis. Arthritis & Rheumatology (Hoboken, NJ) 68 (3): 679–689.

Article  CAS  Google Scholar 

Klasen, C., A. Meyer, P.S. Wittekind, I. Waqué, S. Nabhani, and D.M. Kofler. 2019. Prostaglandin receptor EP4 expression by Th17 cells is associated with high disease activity in ankylosing spondylitis. Arthritis Research & Therapy 21 (1): 159.

Article  CAS  Google Scholar 

Gaston, J.S.H., and D.R. Jadon. 2017. Th17 cell responses in spondyloarthritis. Best practice & research Clinical Rheumatology 31 (6): 777–796.

Article  CAS  Google Scholar 

Chen, L., M.H. Al-Mossawi, A. Ridley, T. Sekine, A. Hammitzsch, J. de Wit, D. Simone, H. Shi, F. Penkava, M. Kurowska-Stolarska, et al. 2017. miR-10b-5p is a novel Th17 regulator present in Th17 cells from ankylosing spondylitis. Annals of the Rheumatic Diseases 76 (3): 620–625.

Article  CAS  PubMed  Google Scholar 

McGinty, J., N. Brittain, and T.J. Kenna. 2020. Looking beyond Th17 cells: A role for Tr1 cells in ankylosing spondylitis? Frontiers in Immunology 11: 608900.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pedersen, S.J., and W.P. Maksymowych. 2018. Beyond the TNF-α inhibitors: New and emerging targeted therapies for patients with axial spondyloarthritis and their relation to pathophysiology. Drugs 78 (14): 1397–1418.

Article  CAS  PubMed  Google Scholar 

Baeten, D., J. Sieper, J. Braun, X. Baraliakos, M. Dougados, P. Emery, A. Deodhar, B. Porter, R. Martin, M. Andersson, et al. 2015. Secukinumab, an interleukin-17A inhibitor, in ankylosing spondylitis. The New England Journal of Medicine 373 (26): 2534–2548.

Article  CAS  PubMed  Google Scholar 

Antignano, F., and C. Zaph. 2015. Regulation of CD4 T-cell differentiation and inflammation by repressive histone methylation. Immunology and Cell Biology 93 (3): 245–252.

Article  CAS  PubMed  Google Scholar 

Del Vescovo, S., V. Venerito, C. Iannone, and G. Lopalco. 2023. Uncovering the underworld of axial spondyloarthritis. International Journal of Molecular Sciences 24 (7): 6463.

Article  PubMed  PubMed Central  Google Scholar 

Roudier, F., I. Ahmed, C. Berard, A. Sarazin, T. Mary-Huard, S. Cortijo, D. Bouyer, E. Caillieux, E. Duvernois-Berthet, L. Al-Shikhley, et al. 2011. Integrative epigenomic mapping defines four main chromatin states in arabidopsis. The EMBO Journal 30 (10): 1928–1938.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tang, H., S. An, H. Zhen, and F. Chen. 2014. Characterization of combinatorial histone modifications on lineage-affiliated genes during hematopoietic stem cell myeloid commitment. Acta Biochimica et Biophysica Sinica 46 (10): 894–901.

Article  CAS  PubMed  Google Scholar 

Zhang, X., H. Wen, and X. Shi. 2012. Lysine methylation: Beyond histones. Acta Biochimica et Biophysica Sinica 44 (1): 14–27.

Article  PubMed  Google Scholar 

Agger, K., P.A. Cloos, J. Christensen, D. Pasini, S. Rose, J. Rappsilber, I. Issaeva, E. Canaani, A.E. Salcini, and K. Helin. 2007. UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development. Nature 449 (7163): 731–734.

Article  CAS  PubMed  Google Scholar 

Schuettengruber, B., H.M. Bourbon, L. Di Croce, and G. Cavalli. 2017. Genome regulation by polycomb and trithorax: 70 years and counting. Cell 171 (1): 34–57.

Article  CAS  PubMed  Google Scholar 

Hubner, M.R., and D.L. Spector. 2010. Role of H3K27 demethylases Jmjd3 and UTX in transcriptional regulation. Cold Spring Harbor Symposia on Quantitative Biology 75: 43–49.

Article  CAS  PubMed  Google Scholar 

Duan, R., W. Du, and W. Guo. 2020. EZH2: A novel target for cancer treatment. Journal of Hematology & Oncology 13 (1): 104.

Article  CAS  Google Scholar 

Hoffmann, F., D. Niebel, P. Aymans, S. Ferring-Schmitt, D. Dietrich, and J. Landsberg. 2020. H3K27me3 and EZH2 expression in melanoma: Relevance for melanoma progression and response to immune checkpoint blockade. Clinical Epigenetics 12 (1): 24.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu, Z., W. Cao, L. Xu, X. Chen, Y. Zhan, Q. Yang, S. Liu, P. Chen, Y. Jiang, X. Sun, et al. 2015. The histone H3 lysine-27 demethylase Jmjd3 plays a critical role in specific regulation of Th17 cell differentiation. Journal of Molecular Cell Biology 7 (6): 505–516.

Article  CAS  PubMed  Google Scholar 

Yang, X.P., K. Jiang, K. Hirahara, G. Vahedi, B. Afzali, G. Sciume, M. Bonelli, H.W. Sun, D. Jankovic, Y. Kanno, et al. 2015. EZH2 is crucial for both differentiation of regulatory T cells and T effector cell expansion. Scientific Reports 5: 10643.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guendisch, U., J. Weiss, F. Ecoeur, J.C. Riker, K. Kaupmann, J. Kallen, S. Hintermann, D. Orain, J. Dawson, A. Billich, et al. 2017. Pharmacological inhibition of RORgammat suppresses the Th17 pathway and alleviates arthritis in vivo. PLoS ONE 12 (11): e0188391.

Article  PubMed  PubMed Central  Google Scholar 

Unutmaz, D. 2009. RORC2: The master of human Th17 cell programming. European Journal of Immunology 39 (6): 1452–1455.

Article  CAS  PubMed  Google Scholar 

Huh, J.R., M.W. Leung, P. Huang, D.A. Ryan, M.R. Krout, R.R. Malapaka, J. Chow, N. Manel, M. Ciofani, S.V. Kim, et al. 2011. Digoxin and its derivatives suppress TH17 cell differentiation by antagonizing RORgammat activity. Nature 472 (7344): 486–490.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xia, L., E. Tian, M. Yu, C. Liu, L. Shen, Y. Huang, Z. Wu, J. Tian, K. Yu, Y. Wang, et al. 2022. RORγt agonist enhances anti-PD-1 therapy by promoting monocyte-derived dendritic cells through CXCL10 in cancers. Journal of Experimental & Clinical Cancer Research : CR 41 (1): 155.

Article  CAS  PubMed Central  Google Scholar 

Yahia-Cherbal, H., M. Rybczynska, D. Lovecchio, T. Stephen, C. Lescale, K. Placek, J. Larghero, L. Rogge, and E. Bianchi. 2019. NFAT primes the human RORC locus for RORγt expression in CD4+ T cells. Nature Communications 10 (1): 4698.

Article  PubMed  PubMed Central  Google Scholar 

Chaudhry, A., D. Rudra, P. Treuting, R.M. Samstein, Y. Liang, A. Kas, and A.Y. Rudensky. 2009. CD4+ regulatory T cells control TH17 responses in a Stat3-dependent manner. Science 326 (5955): 986–991.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Burchfield, J.S., Q. Li, H.Y. Wang, and R.F. Wang. 2015. JMJD3 as an epigenetic regulator in development and disease. The International Journal of Biochemistry & Cell Biology 67: 148–157.

Article  CAS  Google Scholar 

Cohen, C.J., S.Q. Crome, K.G. MacDonald, E.L. Dai, D.L. Mager, and M.K. Levings. 2011. Human Th1 and Th17 cells exhibit epigenetic stability at signature cytokine and transcription factor loci. Journal of Immunology 187 (11): 5615–5626.

Article  CAS  Google Scholar 

Hanisch, U.K. 2014. Linking STAT and TLR signaling in microglia: A new role for the histone demethylase Jmjd3. Journal of Molecular Medicine 92 (3): 197–200.

Article  PubMed  Google Scholar 

Taams, L.S., K.J.A. Steel, U. Srenathan, L.A. Burns, and B.W. Kirkham. 2018. IL-17 in the immunopathogenesis of spondyloarthritis. Nature Reviews Rheumatology 14 (8): 453–466.

Article  CAS  PubMed  Google Scholar 

Cua, D.J., and C.M. Tato. 2010. Innate IL-17-producing cells: The sentinels of the immune system. Nature Reviews Immunology 10 (7): 479–489.

Article  CAS  PubMed  Google Scholar